Can seven tasks help distinguish schizophrenia and schizoaffective disorder from healthy people
Official title: Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium
Run by Washington University School of Medicine · NCT07853807 · Data updated 2026-11-12
The study tests seven cognitive tasks to see if they can tell apart people with schizophrenia or schizoaffective disorder from healthy adults and predict symptoms like hallucinations and delusions.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 59 Years |
| Sex | All |
| Enrollment | 325 (estimated) |
| Sponsor | Washington University School of Medicine Academic / other |
| Locations | 5 sites (Irvine, California and 4 other locations) |
| Status | Recruiting |
| Started | November 15, 2026 |
| Main results expected | June 30, 2031 |
| Study ends | June 30, 2031 |
| Registry record updated | November 9, 2026 |
| Trial ID | NCT07853807 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18-59 with schizophrenia or schizoaffective disorder or healthy controls matched on age and demographics.
✕Probably not a fit
Individuals with recent substance use disorders, significant head injury, or neurological disease may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Study 1 will have participants complete seven tasks across four sessions with EEG recording to compare their performance across diagnostic groups. Researchers will examine how task-based models relate to clinical measures of hallucinations and delusions, and whether these model parameters offer advantages over standard behavioral methods. The project also probes whether hallucinations and delusions arise from shared or separate underlying processes and whether task-based metrics improve prediction of psychotic symptoms. Participants will undergo comprehensive clinical interviews, self-report assessments, and neurocognitive testing to characterize function and symptoms. The study will recruit adults with schizophrenia or schizoaffective disorder and matched healthy controls, and will analyze psychometric properties and variance explained by the tasks.
Why it matters
Potential benefit: If successful, the tasks could provide more precise tools for diagnosing and predicting symptom trajectories in psychotic disorders.
How similar studies have gone: Previous work has shown that cognitive and EEG-based tasks can differentiate psychotic disorders from controls, though this specific multi-task, model-based approach is being tested for added precision.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: General Inclusion 1. age 18 to 59 2. no substance disorder in past six months (confirmed with urine drug screens and breathalyzers); 3. no clinically significant head injury or neurological disease. 4. Wechsler Test of Adult Reading (WTAR) score =16+. Group Specific Criteria: Schizophrenia/Schizoaffective Disorder (SZ): 1. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) diagnosis of schizophrenia or schizoaffective; 2. no medication changes in prior month or anticipated in the next month or not taking medications 3. outpatient or partial hospital if unmedicated Healthy Controls (HC): 1. no Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) Psychosis or Bipolar Disorder; 2. no family history of psychosis or bipolar Exclusion Criteria: Healthy Controls (HC): 1. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) Psychosis or Bipolar Disorder diagnosis 2. Family history of psychosis or bipolar Schizophrenia/Schizoaffective Disorder (SZ/SZA): additional exclusion criteria for the unmedicated individuals are: 1. not in acute exacerbation requiring immediate hospitalization or treatment 2. self-reported medication non-compliance for at least the four previous weeks 3)never having started medications
Where it's running
-
University of California, Irvine
Irvine, California, United States Recruiting -
The University of Chicago
Chicago, Illinois, United States Recruiting -
University of Maryland, Baltimore
Baltimore, Maryland, United States Recruiting -
University of Minnesota
Minneapolis, Minnesota, United States Recruiting -
Washington University
St Louis, Missouri, United States Recruiting
Study contacts
- Principal investigator: Deanna Barch, Ph.D. — Washington University School of Medicine
- Study coordinator: Deanna Barch, Ph.D.
- Email: dbarch@wustl.edu
- Phone: 314-935-8729
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How age affects germinal center responses after flu and rabies vaccines
Researchers will test how the immune system responds to flu and rabies vaccines in younger adults (18–40) and older adults (65+).
-
Magnetic field maps with NV sensors for non-invasive heart measurements
This study tests whether diamond-based NV magnetometers can non-invasively detect and map the heart's magnetic field in healthy adults.
-
Theta-Burst Transcranial Magnetic Stimulation for Treatment-Resistant Auditory Hallucinations
This study tests whether theta-burst transcranial magnetic stimulation can lessen persistent auditory verbal hallucinations in adults with schizophrenia-spectrum or psychotic disorders who have not responded to antipsychotic meds.
-
Methylation analyses using home-based self-sampling in women with and without gynecological disease
This study tests whether self-collected urine and vaginal samples can reveal DNA methylation markers that distinguish people with gynecological (pre-)cancers from cancer-free controls.
-
Cognitive Tasks and Models in a Large Online Sample
This study tests cognitive tasks and computational models in a large online group to see if these tools can help predict symptoms like hallucinations and delusions in the general population.
-
Omega-3 status in healthy adults: comparing different fish-oil and algae-oil products
This study tests whether various fish-oil and algae-oil products can raise the Omega-3 Index in healthy adults who don’t eat much fatty fish.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.